About Apieron
Apieron is a company based in Menlo Park (United States) founded in 2001 by Bhairavi Parikh, PhD was acquired by Aerocrine in May 2010. It operates as a B2B. Apieron has raised $68.52 million across 5 funding rounds from investors including Canaan, Aerocrine and ONSET Ventures. Apieron operates in a competitive market with competitors including Eversens, Linshom, Deep Breath Intelligence, Deversify and Medipines, among others.
- Headquarter Menlo Park, United States
- Founders Bhairavi Parikh, PhD
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apieron
Apieron has successfully raised a total of $68.52M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $25 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Apieron
Apieron has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Canaan, Aerocrine and ONSET Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked |
Investor details for Apieron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apieron
Investment portfolio details for Apieron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apieron
Detailed financials for Apieron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apieron Comparisons
Peer comparison for Apieron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apieron
Apieron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eversens, Linshom, Deep Breath Intelligence, Deversify and Medipines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of non-invasive diagnostic system to detect bio-markers
|
|
| Locked | Locked | Locked |
Developer of respiratory monitoring devices
|
|
| Locked | Locked | Locked |
AI and mass spectrometry platforms for personalized medicine are developed.
|
|
| Locked | Locked | Locked |
Breath analyzers for acetone concentration in exhaled air are developed.
|
|
| Locked | Locked | Locked |
Non-invasive respiratory measurement devices are developed for gas exchange assessment.
|
Detailed competitors of Apieron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apieron
Complete news archive for Apieron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apieron
Apieron was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Apieron is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Apieron is a funded company, having raised a total of $68.52M across 5 funding rounds to date.
Apieron, based in Menlo Park, focuses on providing healthcare solutions, developing medical devices, respiratory care, and asthma monitoring. Functions as an asthma monitoring device for health management. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Apieron has 6 investors. Key investors include Canaan, Aerocrine, ONSET Ventures, Alliance Technology Ventures, and DFJ.